SlideShare a Scribd company logo
Experimental evaluation of
anti-arrhythmic drugs
Dr Kirtan Bhatt
Post-graduate,
KIMS, Bangalore
Protocol
• Introduction
• Recording of ECG in experimental animals
• Experimental models
In vitro models
In vivo models
1. Chemically induced arrhythmias
2. Electrically induced arrhythmias
3. Mechanically induced arrhythmias
4. Exercise induced arrhythmias
Genetic models
Cell culture models
• Conclusion
Introduction and historical landmarks
1897 – Oskar/Oscar Langeddorrf
1975 – Laszlo Szekeres, Papp
1979 – Laszlo Szekeres
1984 – Winslow
1984 – Wilson
1988 – Walker
1993 – Cheung
Laszlo Szekeres
Recording of ECG in experimental animals
• Recording of the ECG is an essential tool in the evaluation of anti-
arrhythmic drugs. The pattern of ECG varies between species.
• Some changes:
Lead II between right foreleg and left hindleg, which is in line with neutrally
placed heart
Lead I between right and left foreleg stated to lie in the axis of horizontal
heart
Lead III between left foreleg and left hindleg in line with the vertical heart.
Along with these, unipolar leads (V1 to V6) and aVL, aVR and aVF.
• The procedure for recording of ECG in rats is as follows:
• Male Sprague Dawley rats 250-300 g
anaethetised by IP pentobarbitone 50 mg/kg
• Right jugular vein – injections and left
coronary for BP
• Lead II
• Electrode constructed with 26 gauge needles
placed subcutaneously
• Paper speed 100 mm/s on a student
physiograph
• Sensitivity of student physiograph adjusted
to provide deflection of 30 mm for 1mV
standard square wave
ECG recording (cont…)
• Variables measured:
 σ T
 P-R interval
 QRS
 Q-T
 RSh
• Some differences between ECG of humans and smaller animals
 Heart rate is very high
 More prominent QRS
 ST segment is generally absent
In vitro methods
• Isolated Guinea Pig papillary muscle
1. Characterization of anti-arrhythmic activity
2. Action potential and refractory period
• Lagendorff technique
• Ach or potassium induced arrhythmias
Isolated guinea pig papillary muscle
• A simple and accurate method to classify anti-arrhythmic drugs into
class I, II, III and IV.
• Based on the changes seen in
– Tension developed in papillary muscle (DT)
– Excitability (EX)
– Effective refractory period
Guinea pig (200-400 g) stunned and carotid artery severed
Thoracic cage opened and heart removed
Myocardium placed into a container filled with pre-oxygenated and prewarmed PSS
Right ventricle opened and tendinous end of papillary muscle ligated with a silk thread (connected
to a force transducer ).
Chordae tendinae freed from the ventricle and the other end clamped into a tissue holder and
platinum wire electrodes attached at its end
Preparation transferred to PSS and maintained at a constant temp and pressure
Muscles are field stimulated to contract
isometrically at stimulus duration of 1 ms at 1 Hz
frequency
Pulses delivered through a Grass constant voltage
stimulator and tension recorded through a
polygraph
Force frequency curve obtained by measuring
developed tension over a range of stimulation
frequencies
Percentage change in developed tension, ERP and
the strength duration curve noted
Action potential and refractory period in Guinea
pig muscle
• Guinea pigs of Marioth strain of 250-300 g
• Two strongest papillary muscles from LV taken
• Standard microelectrode technique is used to measure AP
• Stimulation is given by rectangular pulses of 1 V and 1ms duration at
500ms interval
• Second stimuli given in decremental intervals till contraction ceases
Lagendorff technique
Principle
• The heart is perfused in a retrograde direction from the aorta either
at a constant pressure or a constant flow with oxygenated saline
solutions
Animals
Albino rats (300g and at least 1 year of age)
New Zealand rabbits (1.5-3 kg and 3 years of age)
Guinea pig (300-450 g and 2-3 years of age)
Animal housing conditions
- Housed at ambient temperature (23⁰C ± 2⁰C)
- 12:12 hour light and dark cycle
- Free access to tap water
- Food ad libitum
Precautions
- Pretreatment with heparin
- Maintenance of PSS flow rate to prevent edema of cardiac tissue
- Prevent air bubble entry
- Maintain sufficient hydrostatic pressure by maintaining distance between
heart and the PSS reservoir
- Cannula shouldn’t penetrate the aortic valve
Guinea pigs sacrificed by
stunning
Heart removed as
quickly as possible and
placed in a dish
containing PSS at 37⁰C
Cannula inserted into
aorta and tied and the
heart is perfused with
oxygenated PSSsolution
Oxygenated PSS solution
perfused at a constant
pressure of 40 mmHg at
37⁰C
Test compound
administered
Epicardial ECG electrode
used for pulsatile
stimulation and
arrhythmia induction
Steel hook with a string
is attached to the apex
FOC measured
isometrically by a force
transducer and recorded
on a polygraph
Incidence and duration
of VF or VT recorded in
both test and control
groups
Ach or potassium induced arrhythmias
• New Zealand white rabbits weighing 0.5-3 kg are used
New Zealand white
rabbits sacrificed and
heart removed quickly
Atria dissected and
attached to an
electrode in lower part
of bath and suspended
Fibrillation produced
when atria exposed to
Ach 3*10-4 or KCl 0.10 g
After 5 minutes of
exposure, rectangular
pulses given (0.75 ms
duration, 10V and)
Controlled arrhythmias
are produced and
allowed to continue for
6-10 minutes
30 minutes rest period
Fibrillation induced and
allowed to continue for
3 minutes
Test compound is
added to bath
Chemically induced arrhythmias
Chemical agents capable of producing arrhythmias are:
Anaesthetic agents like chloroform, ether, halothane (sensitizing agents)
followed by a precipitating stimulus such as IV adrenaline, aconitine, cardiac
glycosides (ouabain), veratrum alkaloids.
The sensitivity of these arrhythmogenic substances differs from species to
species.
Various models for chemically induced arrhythmias are:
1. Aconitine induced arrhythmia in rats
2. Digoxin-induced arrhythmia in Guinea pigs
3. Strophanthin/Ouabain induced arrhythmia in dog
4. Adrenaline induced arrhythmia in dogs
5. Calcium-induced arrhythmia in Wistar albino rats
Aconitine induced arrhythmia in rats
• Aconitine is a plant alkaloid - Aconitum
napellus root
• Can persistently activate sodium channels -->
ventricular arrhythmia in anaesthetised rats.
• Drugs with anti-arrhythmic property can be
tested in aconitine-intoxicated rats.
Procedure:
Animal – Male Ivanovas rats weighing 300-400 g
Anaesthesia – Intraperitoneal injection 1.25 g/kg urethane
• 5 μg/kg aconitine dissolved in 0.1 N HNO3 is infused into saphenous vein at
0.1 ml/min
• Lead II is recorded every 30 seconds
• Test compound given – oral or IV (3 mg/kg 5 minutes before aconitine)
Evaluation
The anti-arrhythmic effects are measured by amount of aconitine/100g
(duration of infusion) which includes
• Ventricular extra-systoles
• VT
• VF
• Death
Statistical significance is assessed by student’s t-test
Digoxin induced ventricular arrhythmias
• Overdose of cardiac glycosides can cause ventricular extra-systoles, VF
and death
• The occurrence of these symptoms can be delayed by anti-arrhythmic
drugs
Procedure
Animal – Male guinea pig (Marioth strain) weighing 350-500 g
Anaesthesia – 35 mg/kg pentobarbital sodium intraperitoneal
Trachea, a jugular
vein and a carotid
artery catheterised
Positive pressure
ventilation given with
a respiratory pump
BP monitored in the
carotid
Digoxin infused into
jugular vein 85 μg/kg
in 0.266 ml/min until
cardiac arrest
Treated group
receives the test drug
orally/IV 1 minute
prior to infusion
Control group
receives only digoxin
Period till ventricular
extra-systoles, VF and
cardiac arrest is noted
Evaluation
Doses of digoxin required to induce ventricular extra-systoles or VF or
cardiac arrest after treatment with anti-arrhythmic drugs are compared
statistically with student’s t-test
Strophanthin/Ouabain induced arrhythmia in dogs
Animal – Male or female dogs weighing 20 kg approximately
Anaesthesia – IV pentobarbital sodium 30-40 mg/kg
• Two peripheral veins are cannulated for administration of arrhythmia
inducing substance (V. brachialis) and for test substance (V. cephalica
antebrachii)
• Duodenum is cannulated for intraduodenal administration
• ECG is recorded with needle electrodes from lead II. Heart frequency
is derived from R-peaks of ECG.
• Strophanthin K is given continuous IV infusion at 3μg/kg/min.
• Signs of intoxication in the form of VT or multifocal ventricular arrhythmias
are seen in 30-40 minutes.
• Infusion is stopped. When the arrhythmia is stable for 10 minutes, the test
substance is given IV 1-5 mg/kg or intraduodenally 10-30 mg/kg.
• ECG is recorded at -0.5, 1, 2, 5 and 10 minutes following the test drug
administration
Evaluation:
For IV test drug administration
- Considered anti-arrhythmic if extra-systoles disappear immediately
- Increase the dose every 15 minutes if they don’t
For ID test drug administration
- Considered anti-arrhythmic if extra-systoles disappear in 15 minutes
- “no effect” if it doesn’t improve intoxication in 60 minutes
Calcium induced arrhythmias
Al-Obaid et al in 1998 used calcium chloride induced arrhythmias for
anti-arrhythmic activity evaluation in anaesthetized male rats
Wistar albino rats weighing 60-130 g are used
Anaesthesia – pentobarbital 60 mg/kg intraperitoneal
Arrhythmia induced
by a single IV
injection 10% CaCl2
(50 mg/kg)
Recovery allowed for
15-20 minutes
Test compound is
administered at
different doses IV
Effect of test
compound on basal
HR noted
After 7 minutes,
CaCl2 re-
administered
Effect of treatment
on induced
arrhythmia noted as
percentage change
Adrenaline induced arrhythmias
• Adrenaline can precipitate arrhythmia at high doses
• Dogs of 10-11 kg are anaesthetized by pentobarbitone sodium 30-40
mg/kg intraperitoneally.
• Adrenaline is given through femoral vein at 2-2.5 mg/kg
• Lead II ECG and atrial ECG are recorded
• Test drug given 3 minutes after adrenaline infusion
Some other models for chemically induced
arrhythmias
1. Mouse chloroform model (Lawson, 1968 and Vargafting, 1969)
2. BaCl2 model (Papp et al, 1967)
3. Benzene vapours induced arrhythmia (Tripathi and Thomas, 1986)
4. Wenzel and Kloeppel demonstrated that arrhythmias could be
induced by changing the medium of cultured heart cells
5. VF production by isoprenaline and COMT inhibitor at high
temperature (Sono et al, 1985)
6. Grayanotoxin – I induced arrhythmia in guinea pigs (Takei et al,
1994)
Electrically induced arrhythmias
1. Ventricular fibrillation electrical threshold
2. Programmed electrical stimulation induced arrhythmia
3. Sudden coronary death model in dogs (Harris dog model)
Ventricular fibrillation electrical threshold
Several electrical stimulation techniques are used to measure VF
threshold:
• Single pulse stimulation
• Train of pulses stimulation
• Continuous 50 Hz stimulation
• Sequential pulse stimulation
Animals – adult dogs weighing 8-12 kg
Anaesthesia – sodium pentobarbital 35 mg/kg intraperitoneal
Ventilation given with
Harvard respiratory
pump, systolic BP
monitored and body
temperature maintained
with a thermal blanket
Chest opened by a
midline sternotomy and
heart suspended in a
pericardial cradle
Sinus node crushed and
a 2mm diameter Ag-AgCl
stimulating electrode
embedded in a Teflon
disc sutured to ant wall
of LV
3-ms square anodal
constant current pulses
given for 400ms of basic
cycle and prematurely
restimulated
Recording electrode is
placed on the surface
of each ventricle
silver plate is implanted
under the skin in the
right femoral region as
indifferent electrode.
Lead II of the body surface
ECG is monitored.
To determine VF threshold, a
0.2-1.8 second train of 50 Hz
pulses is delivered 100ms
after every 18th basic driving
stimulus.
The current intensity is
increased from the diastolic
threshold in increments of
10μA to 1.0 mA or until VF
occurs.
Defibrillation given when VF
occurs,heart allowed to
recover to control conditions
for 15-20 minutes. Anti-
arrhythmic drugs are given in
the femoral vein.
Evaluation:
VF threshold is determined before and after test drug administration
and compared using student’s t-test.
Programmed electrical stimulation induced
arrhythmias
A ligature is tied around the
artery and needle. The
needle is then removed
which causes stenosis of the
vessel. LAD is perfused for 5
minutes.
Ischemic injury is achieved by
2 hour occlusion of LAD and
then again vessel is perfused
for 2 hours in presence of
stenosis.
During reperfusion, an
epicardial bipolar electrode is
sutured to the IV septum,.
Silver disc electrodes are
implanted SC for ECG
monitoring.
Animals with sustained VT
and VF are taken for study.
HR, ECG are recorded before
the PES is started.
After 6-9 days, the chest is
reopened and PES is
performed through electrode
implanted on non-infarcted
zone with pacing stimuli set
at 200ms.
After 15 pacing stimulation,
an extra stimulus is given
• Test drug is given 30 minutes after the stimulus.
• The minimum intensity of current needed for sustained VF is recorded
before and after test drugs and mean values of 10 experiments are
compared by student’s t-test.
Sudden coronary death model in dogs
• The group of Lucchesi described the experimental dog model for
protection against sudden coronary death.
Animal - Male Mongrel dogs of 14-22 kg weight
Anaesthesia - pentobarbital sodium 30 mg/kg IV.
Direct anodal 15μA current
from 9-V nickel-cadmium
battery passed through a 250
ohm resistor and applied to
electrode in the lumen of LCX.
Cathode connected to a SC
implanted disc electrode and
lead II ECG recorded for 30
seconds every 15 minutes on
a cardio-cassette recorder.
The animals are sacrificed
after 24 hours of constant
anodal current of at the
occurrence of VF.
Heart removed and thrombus
mass in LCX is removed,
weighed.
Heart sectioned and stained
with tetrazolium triphenyl
choride (TTC).
Time of onset of ventricular
ectopy and lethal arrhythmia
recorded using the cassette.
Non-sustained and sustained
tachyarrhythmia are
evaluated
Mechanically induced arrhythmias
Arrhythmias can be induced by directly by ischemia or and also by re-
perfusion. Studies involving both the mechanisms to produce
arrhythmias have been demonstrated.
1. Reperfusion arrhythmias in rats
2. VF after coronary occlusion and reperfusion in dogs
3. Two stage ligation in dogs (The Harris dog model)
Reperfusion arrhythmias in rats
• Ligation of left main coronary artery results in ventricular arrhythmias
and MI.
• ECG is recorded during ligation and also during reperfusion.
• The infarcted tissue is measured by tetrazolium triphenyl chloride
staining
Sprague Dawley
rats (350-400 g)
are anaesthetised
with
pentobarbitone
sodium 60 mg/kg
IP.
The animal is
maintained on
artificial
respiration, jugular
vein is cannulated
for drug
administration.
BP is recorded
from carotid artery
with the help of a
pressure
transducer
connected to a
polygraph.
Chest is opened
and heart is
exposed. The left
coronary artery is
located and ligated
for 15-90 minutes
(in case of infarct
size studies) and
subsequently
reperfused for 30
minutes.
Test drug is given 5 minutes before ligation.
The number of ventricular premature beats, VT and VF
are counted in the occlusion and reperfusion periods.
After the reperfusion period, the animal is sacrificed
and TTC staining is done to measure the infarct size..
Changes in hemodynamic parameters and infarct size in
drug treated animals are compared with control values.
Reperfusion arrhythmias in dogs
• Ligation of coronary artery in dogs may lead to increase in HR, LV end
diastolic pressure, BP and ventricular arrhythmias especially in
reperfusion.
• Animal - Dogs of 20-25 kg weight
• Anaesthesia:
thio-butobarbital sodium 30 mg/kg IP
maintained on IV chloralose 20 mg/kg and 250 mg/kg urethane IV followed
by SC morphine 2 mg/kg.
Changes in
parameters
(mortality,
hemodynamic and
arrhythmia) in drug
treated animals are
compared with
controls.
Coronary artery is
ligated for 90
minutes. Test
compound is given
20 minutes prior to
ligation and
reperfusion is done
after the ligation
period.
LV end diastolic
pressure and HR are
determined from LV
pressure curves.
Myocardial
contractility is
measured as a rise
of ventricular
pressure.
Femoral artery is
cannulated to
measure BP and
connected to a
pressure transducer
and ECG is recorded
continuously in lead
II.
Two stage ligation in dogs (Harris dog model)
• In 1950, Harris found that mortality in dogs after coronary occlusion
with a 2 stage ligation procedure was lower than with 1 stage ligation
Dogs of 8-11 kg are anaesthetised by IV injection of methohexitone sodium 10 mg/kg and
maintained on artificial respiration.
Chest is opened and the heart is exposed.
Left coronary artery is ligated in 2 stages. Two ligatures are tied around the artery and the 21
gauge needle.
1st ligature is tied around and the needle, which is removed
2nd is tied tightly around the artery (after 30 minutes ).
After 24-48 hours of ligation, arrhythmias develop and subside in 3-5 days.
• Lead II ECG, atrial electrogram and mean BP are measured.
• Test drugs are infused 10 minutes after coronary ligation.
• Changes in mortality, hemodynamics and arrhythmias in treated
animals are compared with controls.
Exercise induced ventricular fibrillation
• Billman and his group developed methods to evaluate anti-arrhythmic
drugs for their activity in exercise-plus-ischemia induced arrhythmia
test.
Mongrel dogs 15-19 kg are anaesthetised with sodium
pentobarbitone 10 mg/kg IV, chest cavity opened, heart
exposed and supported in a pericardial cradle.
Around the LCX a 20 MHz pulsed Doppler flow
transducer and hydraulic occluder are placed.
A pair of insulated silver wires are sutured to the
epicardial surface of both the left and right ventricular
electrogram.
A pre-calibrated solid state pressure transducer is
inserted into LV and finally a two stage occlusion of LAD
is done.
Leads are placed
under the skin to
exit on the back of
the animal’s neck.
3-4 weeks after the
production of
ischemia, the
animal is made to
walk on a motor
driven treadmill
during which
susceptibility to VF
is tested.
3 minute warm up
period - animals
run at 6.4 km/hr
(0% grade).
The grade is
increased every 3
minutes from 0%,
4%, 8%, 12% and
16%.
In the last minute
of exercise, the LCX
is occluded, the
treadmill stopped
and occlusion
maintained for an
additional minute.
• Repeated after the test drug and the findings are compared with the
control (saline) group.
• All hemodynamic data (rate of change of LV pressure) are recorded. The
refractory period data, reactive hyperemia response to each occlusion is
averaged and data analysed using ANOVA.
• The effect of intervention on arrhythmia formation are determined by chi-
square test with Yate’s correction.
Cell culture techniques
• Ventricular arrhythmias, especially torsades de pointes can be
evaluated using isolated ventricular myocytes.
• Analysis of action potential and patch clamp techniques in isolated
ventricular myocytes helps us to clarify mechanisms underlying
development of torsades de pointes.
Guinea pigs (250-350 g) are sacrificed by decapitation and their hearts are
removed and perfused retrodradely through the aorta at a rate of 10 ml/min
with oxygenated calcium free HEPES buffered saline at 37⁰C for 5 minutes.
Perfusion with same solution containing 300 U/ml type II collagenase and 0.5-
1.0 U/ml type XIV protease for 8 minutes
HEPES buffered saline containing 0.2mM calcium chloride for additional 5
minutes.
The cells re-suspended in HEPES buffered saline and stored at 24⁰C.
Transmembrane potential is recorded using glass electrodes connected to
the Axoclamp 2A amplifier.
Cells superfused with HEPES buffered saline at a rate of 2 ml/min at 37⁰C.
Passing brief current pulses (1 ms, 1.2 times threshold) through recording
electrode with active bridge current evokes action potentials.
Cells are stimulated at a frequency of 1 Hz during stabilization period and
at a frequencies of 1 and 3 Hz during control and 10 minutes after
superfusion with test drugs at cumulatively increasing drug concentration
Four individual AP are
digitally averaged and
measured for each
condition.
For voltage clamp studies,
microelectrodes made
from square bore,
borosilicate capillary
tubing are filled with 0.5
M potassium gluconate, 25
mM KCl, 5 mM K2ATP.
Voltage clamp is
performed using whole
cell recording mode and
cell perfusion is minimized
by maintaining constant
negative pressure on the
electrode using 1 ml
syringe.
Outward K+ currents are
measured during
superfusion of cells at 2
ml/min with calcium free
HEPES buffered saline.
Concentration response
relations are determined
by measuring AP of
currents in each cell
during control conditions
and during superfusion
with 2 successively
increasing concentrations
of a drug.
Genetically induced arrhythmias
• A certain breed of dogs – German shepherds – exhibit propensity to
sudden death that occurs due to inherited ventricular arrhythmias.
• Death usually occurs in them during sleep or at rest after exercise or
excitement.
• These dogs can be used for screening of potential anti-arrhythmic drugs.
Conclusion
• Species differences do exist in mechanisms producing arrhythmias and no animal can
exactly resemble humans
• However, knowledge acquired from animal studies can help a great deal in devising
therapeutic strategies for both ventricular and supraventricular arrhythmias
• Various animal models can be combined to build novel strategies in management of
arrhythmias

More Related Content

What's hot

Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugs
Abu Sufiyan Chhipa
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
Anurag Chourasia
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
nazuk sharma
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
Dr Roohana Hasan
 
Drug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agentsDrug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agents
Dr. Abhishek Vyas
 
Muscle relaxants by ved prakash
Muscle relaxants by ved prakashMuscle relaxants by ved prakash
Muscle relaxants by ved prakash
vedprakashpanda2
 
Screening of Antidiabetics
Screening of AntidiabeticsScreening of Antidiabetics
Screening of Antidiabetics
Sayli Chaudhari
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
SwaroopaNallabariki
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
Dr. Advaitha MV
 
Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...
SuchiJain7
 
Diuretic Preclinical Screening models
Diuretic Preclinical  Screening models Diuretic Preclinical  Screening models
Diuretic Preclinical Screening models
ABHAYKUMARYADAV6
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
Kundlik Rathod
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
HimikaRathi
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
ShobhiniChandel
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
SONALPANDE5
 
Pharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drugPharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drug
Rakesh Kumar
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
shubhaasharma
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening of anti hypertensives2003
Screening of anti hypertensives2003Screening of anti hypertensives2003
Screening of anti hypertensives2003
Dr. Mallappa Shalavadi
 
SCREENING OF ANALGESICS & ANTIPYRETIC
SCREENING  OF  ANALGESICS & ANTIPYRETICSCREENING  OF  ANALGESICS & ANTIPYRETIC
SCREENING OF ANALGESICS & ANTIPYRETIC
Pranesh Kumar
 

What's hot (20)

Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugs
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
 
Screening antianginal (1)
Screening antianginal (1)Screening antianginal (1)
Screening antianginal (1)
 
Drug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agentsDrug screening methods for antiarrhythmic agents
Drug screening methods for antiarrhythmic agents
 
Muscle relaxants by ved prakash
Muscle relaxants by ved prakashMuscle relaxants by ved prakash
Muscle relaxants by ved prakash
 
Screening of Antidiabetics
Screening of AntidiabeticsScreening of Antidiabetics
Screening of Antidiabetics
 
Screening methods of anti hypertensive agents
Screening methods of anti hypertensive agentsScreening methods of anti hypertensive agents
Screening methods of anti hypertensive agents
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
 
Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...Screening methods for the evaluation of antihypertensive agents activity of a...
Screening methods for the evaluation of antihypertensive agents activity of a...
 
Diuretic Preclinical Screening models
Diuretic Preclinical  Screening models Diuretic Preclinical  Screening models
Diuretic Preclinical Screening models
 
screening model for diabetes
screening model for diabetesscreening model for diabetes
screening model for diabetes
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
Pharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drugPharmacological screening of anti arrhythmic drug
Pharmacological screening of anti arrhythmic drug
 
Antidiabetic screening
Antidiabetic screeningAntidiabetic screening
Antidiabetic screening
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Screening of anti hypertensives2003
Screening of anti hypertensives2003Screening of anti hypertensives2003
Screening of anti hypertensives2003
 
SCREENING OF ANALGESICS & ANTIPYRETIC
SCREENING  OF  ANALGESICS & ANTIPYRETICSCREENING  OF  ANALGESICS & ANTIPYRETIC
SCREENING OF ANALGESICS & ANTIPYRETIC
 

Viewers also liked

Presentation on experimental evaluation of memory enhancers
Presentation on experimental evaluation of memory enhancersPresentation on experimental evaluation of memory enhancers
Presentation on experimental evaluation of memory enhancers
Akhil Agarwal
 
Screening procedure for amnesia
Screening procedure for amnesiaScreening procedure for amnesia
Screening procedure for amnesiaJathin Menon
 
Animal models
Animal modelsAnimal models
Animal models
hishashwati
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Divya Krishnan
 
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
Imhotep Virtual Medical School
 
Screening of antidepressant agents
Screening of antidepressant agentsScreening of antidepressant agents
Screening of antidepressant agents
Dr. Partha Sarkar
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
Jitendra Agrawal
 
Blood cells and hematopoesis
Blood cells and hematopoesis Blood cells and hematopoesis
Blood cells and hematopoesis
wayan sugiritama
 
Pharmacotherapy of hypertension
Pharmacotherapy of hypertensionPharmacotherapy of hypertension
Pharmacotherapy of hypertension
Dr Shahid Saache
 
Antiarrythmics
AntiarrythmicsAntiarrythmics
Antiarrythmicsshabeel pn
 
Calcium Channel Blockers
Calcium Channel Blockers Calcium Channel Blockers
Calcium Channel Blockers
Dr Htet
 
Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)
Muhammad Arsal
 
calcium channel blockers
calcium channel blockerscalcium channel blockers
calcium channel blockers
Docdhingra
 
Forensic medicine (forensic pathology)
Forensic medicine   (forensic pathology)Forensic medicine   (forensic pathology)
Forensic medicine (forensic pathology)MBBS IMS MSU
 
Forensic medicine changes after death
Forensic medicine   changes after deathForensic medicine   changes after death
Forensic medicine changes after deathMBBS IMS MSU
 
1. Introduction to Forensic Medicine
1. Introduction to Forensic Medicine1. Introduction to Forensic Medicine
1. Introduction to Forensic Medicine
Dr. Abhishek Karn
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Dr. Pravin Wahane
 

Viewers also liked (20)

Presentation on experimental evaluation of memory enhancers
Presentation on experimental evaluation of memory enhancersPresentation on experimental evaluation of memory enhancers
Presentation on experimental evaluation of memory enhancers
 
Screening procedure for amnesia
Screening procedure for amnesiaScreening procedure for amnesia
Screening procedure for amnesia
 
Animal models
Animal modelsAnimal models
Animal models
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan
 
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
Lect1 CVS Function, Regulation of Heart and Overview of Therapeutic Goals in ...
 
Screening of antidepressant agents
Screening of antidepressant agentsScreening of antidepressant agents
Screening of antidepressant agents
 
Editd anti arrhythmic
Editd anti arrhythmicEditd anti arrhythmic
Editd anti arrhythmic
 
Animal behavior
Animal behaviorAnimal behavior
Animal behavior
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
 
Blood cells and hematopoesis
Blood cells and hematopoesis Blood cells and hematopoesis
Blood cells and hematopoesis
 
Pharmacotherapy of hypertension
Pharmacotherapy of hypertensionPharmacotherapy of hypertension
Pharmacotherapy of hypertension
 
Antiarrythmics
AntiarrythmicsAntiarrythmics
Antiarrythmics
 
Calcium Channel Blockers
Calcium Channel Blockers Calcium Channel Blockers
Calcium Channel Blockers
 
Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
calcium channel blockers
calcium channel blockerscalcium channel blockers
calcium channel blockers
 
Forensic medicine (forensic pathology)
Forensic medicine   (forensic pathology)Forensic medicine   (forensic pathology)
Forensic medicine (forensic pathology)
 
Forensic medicine changes after death
Forensic medicine   changes after deathForensic medicine   changes after death
Forensic medicine changes after death
 
1. Introduction to Forensic Medicine
1. Introduction to Forensic Medicine1. Introduction to Forensic Medicine
1. Introduction to Forensic Medicine
 
Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy Anti arrhythmic drug thereapy
Anti arrhythmic drug thereapy
 

Similar to Experimental evaluation of anti arrhythmic drugs

sceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdfsceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdf
Apurva Pawar
 
Pharmacological Screening of Anti Arrhythmic Drug
Pharmacological Screening of Anti Arrhythmic DrugPharmacological Screening of Anti Arrhythmic Drug
Pharmacological Screening of Anti Arrhythmic Drug
jatinsaini78
 
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptxSCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
Anagha R Anil
 
PG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxPG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptx
drarunsingh4
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmics
Dr Nikita Ingale
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdf
ceipem
 
Rescuscitation principles
Rescuscitation  principlesRescuscitation  principles
Rescuscitation principlesMohammad Nassr
 
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)
Abhay Rajpoot
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptx
sharanuGurikar
 
Cpr for adults
Cpr for adultsCpr for adults
Cpr for adults
SULE AKIN
 
screening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptxscreening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptx
ShivangiVaish5
 
Case 2 em
Case 2 emCase 2 em
Case 2 em
farranajwa
 
4th-Angina-Myocardial I-CAD-pericarditis
4th-Angina-Myocardial I-CAD-pericarditis4th-Angina-Myocardial I-CAD-pericarditis
4th-Angina-Myocardial I-CAD-pericarditis
cellminaabdulhan01
 
Electrophysiology study and Cardiac Ablation (4).pptx
Electrophysiology study and Cardiac Ablation (4).pptxElectrophysiology study and Cardiac Ablation (4).pptx
Electrophysiology study and Cardiac Ablation (4).pptx
BatMan752678
 
ACLs review.ppt
ACLs review.pptACLs review.ppt
ACLs review.ppt
ishragaish
 
ACLS
ACLSACLS
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
ArpitSuralkar
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
Sanil Varghese
 
Screening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugsScreening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugs
Charu Pundir
 

Similar to Experimental evaluation of anti arrhythmic drugs (20)

sceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdfsceening of anti arrythmic drug by apurva.pdf
sceening of anti arrythmic drug by apurva.pdf
 
Pharmacological Screening of Anti Arrhythmic Drug
Pharmacological Screening of Anti Arrhythmic DrugPharmacological Screening of Anti Arrhythmic Drug
Pharmacological Screening of Anti Arrhythmic Drug
 
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptxSCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
SCREENING MODELS FOR ANTI-ARRTHMICS AND ANTI-ANGINAL AGENTS.pptx
 
PG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptxPG Instruments (Pharmacology).pptx
PG Instruments (Pharmacology).pptx
 
Evaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmicsEvaluation methods of anti-aarhythmics
Evaluation methods of anti-aarhythmics
 
Acls mega code pdf
Acls mega code pdfAcls mega code pdf
Acls mega code pdf
 
Rescuscitation principles
Rescuscitation  principlesRescuscitation  principles
Rescuscitation principles
 
ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)ACLS (Advanced cardiac life support)
ACLS (Advanced cardiac life support)
 
Antiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptxAntiarrhytmics screening models.pptx
Antiarrhytmics screening models.pptx
 
Cpr for adults
Cpr for adultsCpr for adults
Cpr for adults
 
screening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptxscreening of antihypertensive drugs.pptx
screening of antihypertensive drugs.pptx
 
Case 2 em
Case 2 emCase 2 em
Case 2 em
 
4th-Angina-Myocardial I-CAD-pericarditis
4th-Angina-Myocardial I-CAD-pericarditis4th-Angina-Myocardial I-CAD-pericarditis
4th-Angina-Myocardial I-CAD-pericarditis
 
Electrophysiology study and Cardiac Ablation (4).pptx
Electrophysiology study and Cardiac Ablation (4).pptxElectrophysiology study and Cardiac Ablation (4).pptx
Electrophysiology study and Cardiac Ablation (4).pptx
 
ACLs review.ppt
ACLs review.pptACLs review.ppt
ACLs review.ppt
 
ACLS
ACLSACLS
ACLS
 
screening method of cardiovascular activity
screening method of cardiovascular activityscreening method of cardiovascular activity
screening method of cardiovascular activity
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
 
Cpr 2010
Cpr 2010Cpr 2010
Cpr 2010
 
Screening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugsScreening methods for antianginal & antimalarial drugs
Screening methods for antianginal & antimalarial drugs
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 

Experimental evaluation of anti arrhythmic drugs

  • 1. Experimental evaluation of anti-arrhythmic drugs Dr Kirtan Bhatt Post-graduate, KIMS, Bangalore
  • 2. Protocol • Introduction • Recording of ECG in experimental animals • Experimental models In vitro models In vivo models 1. Chemically induced arrhythmias 2. Electrically induced arrhythmias 3. Mechanically induced arrhythmias 4. Exercise induced arrhythmias Genetic models Cell culture models • Conclusion
  • 3. Introduction and historical landmarks 1897 – Oskar/Oscar Langeddorrf 1975 – Laszlo Szekeres, Papp 1979 – Laszlo Szekeres 1984 – Winslow 1984 – Wilson 1988 – Walker 1993 – Cheung Laszlo Szekeres
  • 4. Recording of ECG in experimental animals • Recording of the ECG is an essential tool in the evaluation of anti- arrhythmic drugs. The pattern of ECG varies between species. • Some changes: Lead II between right foreleg and left hindleg, which is in line with neutrally placed heart Lead I between right and left foreleg stated to lie in the axis of horizontal heart Lead III between left foreleg and left hindleg in line with the vertical heart. Along with these, unipolar leads (V1 to V6) and aVL, aVR and aVF. • The procedure for recording of ECG in rats is as follows:
  • 5. • Male Sprague Dawley rats 250-300 g anaethetised by IP pentobarbitone 50 mg/kg • Right jugular vein – injections and left coronary for BP • Lead II • Electrode constructed with 26 gauge needles placed subcutaneously • Paper speed 100 mm/s on a student physiograph • Sensitivity of student physiograph adjusted to provide deflection of 30 mm for 1mV standard square wave
  • 6. ECG recording (cont…) • Variables measured:  σ T  P-R interval  QRS  Q-T  RSh • Some differences between ECG of humans and smaller animals  Heart rate is very high  More prominent QRS  ST segment is generally absent
  • 7. In vitro methods • Isolated Guinea Pig papillary muscle 1. Characterization of anti-arrhythmic activity 2. Action potential and refractory period • Lagendorff technique • Ach or potassium induced arrhythmias
  • 8. Isolated guinea pig papillary muscle • A simple and accurate method to classify anti-arrhythmic drugs into class I, II, III and IV. • Based on the changes seen in – Tension developed in papillary muscle (DT) – Excitability (EX) – Effective refractory period
  • 9. Guinea pig (200-400 g) stunned and carotid artery severed Thoracic cage opened and heart removed Myocardium placed into a container filled with pre-oxygenated and prewarmed PSS Right ventricle opened and tendinous end of papillary muscle ligated with a silk thread (connected to a force transducer ). Chordae tendinae freed from the ventricle and the other end clamped into a tissue holder and platinum wire electrodes attached at its end Preparation transferred to PSS and maintained at a constant temp and pressure
  • 10. Muscles are field stimulated to contract isometrically at stimulus duration of 1 ms at 1 Hz frequency Pulses delivered through a Grass constant voltage stimulator and tension recorded through a polygraph Force frequency curve obtained by measuring developed tension over a range of stimulation frequencies Percentage change in developed tension, ERP and the strength duration curve noted
  • 11. Action potential and refractory period in Guinea pig muscle • Guinea pigs of Marioth strain of 250-300 g • Two strongest papillary muscles from LV taken • Standard microelectrode technique is used to measure AP • Stimulation is given by rectangular pulses of 1 V and 1ms duration at 500ms interval • Second stimuli given in decremental intervals till contraction ceases
  • 12. Lagendorff technique Principle • The heart is perfused in a retrograde direction from the aorta either at a constant pressure or a constant flow with oxygenated saline solutions Animals Albino rats (300g and at least 1 year of age) New Zealand rabbits (1.5-3 kg and 3 years of age) Guinea pig (300-450 g and 2-3 years of age)
  • 13. Animal housing conditions - Housed at ambient temperature (23⁰C ± 2⁰C) - 12:12 hour light and dark cycle - Free access to tap water - Food ad libitum Precautions - Pretreatment with heparin - Maintenance of PSS flow rate to prevent edema of cardiac tissue - Prevent air bubble entry - Maintain sufficient hydrostatic pressure by maintaining distance between heart and the PSS reservoir - Cannula shouldn’t penetrate the aortic valve
  • 14.
  • 15. Guinea pigs sacrificed by stunning Heart removed as quickly as possible and placed in a dish containing PSS at 37⁰C Cannula inserted into aorta and tied and the heart is perfused with oxygenated PSSsolution Oxygenated PSS solution perfused at a constant pressure of 40 mmHg at 37⁰C Test compound administered Epicardial ECG electrode used for pulsatile stimulation and arrhythmia induction Steel hook with a string is attached to the apex FOC measured isometrically by a force transducer and recorded on a polygraph Incidence and duration of VF or VT recorded in both test and control groups
  • 16. Ach or potassium induced arrhythmias • New Zealand white rabbits weighing 0.5-3 kg are used
  • 17. New Zealand white rabbits sacrificed and heart removed quickly Atria dissected and attached to an electrode in lower part of bath and suspended Fibrillation produced when atria exposed to Ach 3*10-4 or KCl 0.10 g After 5 minutes of exposure, rectangular pulses given (0.75 ms duration, 10V and) Controlled arrhythmias are produced and allowed to continue for 6-10 minutes 30 minutes rest period Fibrillation induced and allowed to continue for 3 minutes Test compound is added to bath
  • 18. Chemically induced arrhythmias Chemical agents capable of producing arrhythmias are: Anaesthetic agents like chloroform, ether, halothane (sensitizing agents) followed by a precipitating stimulus such as IV adrenaline, aconitine, cardiac glycosides (ouabain), veratrum alkaloids. The sensitivity of these arrhythmogenic substances differs from species to species.
  • 19. Various models for chemically induced arrhythmias are: 1. Aconitine induced arrhythmia in rats 2. Digoxin-induced arrhythmia in Guinea pigs 3. Strophanthin/Ouabain induced arrhythmia in dog 4. Adrenaline induced arrhythmia in dogs 5. Calcium-induced arrhythmia in Wistar albino rats
  • 20. Aconitine induced arrhythmia in rats • Aconitine is a plant alkaloid - Aconitum napellus root • Can persistently activate sodium channels --> ventricular arrhythmia in anaesthetised rats. • Drugs with anti-arrhythmic property can be tested in aconitine-intoxicated rats.
  • 21. Procedure: Animal – Male Ivanovas rats weighing 300-400 g Anaesthesia – Intraperitoneal injection 1.25 g/kg urethane • 5 μg/kg aconitine dissolved in 0.1 N HNO3 is infused into saphenous vein at 0.1 ml/min • Lead II is recorded every 30 seconds • Test compound given – oral or IV (3 mg/kg 5 minutes before aconitine)
  • 22. Evaluation The anti-arrhythmic effects are measured by amount of aconitine/100g (duration of infusion) which includes • Ventricular extra-systoles • VT • VF • Death Statistical significance is assessed by student’s t-test
  • 23. Digoxin induced ventricular arrhythmias • Overdose of cardiac glycosides can cause ventricular extra-systoles, VF and death • The occurrence of these symptoms can be delayed by anti-arrhythmic drugs Procedure Animal – Male guinea pig (Marioth strain) weighing 350-500 g Anaesthesia – 35 mg/kg pentobarbital sodium intraperitoneal
  • 24. Trachea, a jugular vein and a carotid artery catheterised Positive pressure ventilation given with a respiratory pump BP monitored in the carotid Digoxin infused into jugular vein 85 μg/kg in 0.266 ml/min until cardiac arrest Treated group receives the test drug orally/IV 1 minute prior to infusion Control group receives only digoxin Period till ventricular extra-systoles, VF and cardiac arrest is noted
  • 25. Evaluation Doses of digoxin required to induce ventricular extra-systoles or VF or cardiac arrest after treatment with anti-arrhythmic drugs are compared statistically with student’s t-test
  • 26. Strophanthin/Ouabain induced arrhythmia in dogs Animal – Male or female dogs weighing 20 kg approximately Anaesthesia – IV pentobarbital sodium 30-40 mg/kg • Two peripheral veins are cannulated for administration of arrhythmia inducing substance (V. brachialis) and for test substance (V. cephalica antebrachii) • Duodenum is cannulated for intraduodenal administration • ECG is recorded with needle electrodes from lead II. Heart frequency is derived from R-peaks of ECG.
  • 27. • Strophanthin K is given continuous IV infusion at 3μg/kg/min. • Signs of intoxication in the form of VT or multifocal ventricular arrhythmias are seen in 30-40 minutes. • Infusion is stopped. When the arrhythmia is stable for 10 minutes, the test substance is given IV 1-5 mg/kg or intraduodenally 10-30 mg/kg. • ECG is recorded at -0.5, 1, 2, 5 and 10 minutes following the test drug administration
  • 28. Evaluation: For IV test drug administration - Considered anti-arrhythmic if extra-systoles disappear immediately - Increase the dose every 15 minutes if they don’t For ID test drug administration - Considered anti-arrhythmic if extra-systoles disappear in 15 minutes - “no effect” if it doesn’t improve intoxication in 60 minutes
  • 29. Calcium induced arrhythmias Al-Obaid et al in 1998 used calcium chloride induced arrhythmias for anti-arrhythmic activity evaluation in anaesthetized male rats Wistar albino rats weighing 60-130 g are used Anaesthesia – pentobarbital 60 mg/kg intraperitoneal
  • 30. Arrhythmia induced by a single IV injection 10% CaCl2 (50 mg/kg) Recovery allowed for 15-20 minutes Test compound is administered at different doses IV Effect of test compound on basal HR noted After 7 minutes, CaCl2 re- administered Effect of treatment on induced arrhythmia noted as percentage change
  • 31. Adrenaline induced arrhythmias • Adrenaline can precipitate arrhythmia at high doses • Dogs of 10-11 kg are anaesthetized by pentobarbitone sodium 30-40 mg/kg intraperitoneally. • Adrenaline is given through femoral vein at 2-2.5 mg/kg • Lead II ECG and atrial ECG are recorded • Test drug given 3 minutes after adrenaline infusion
  • 32. Some other models for chemically induced arrhythmias 1. Mouse chloroform model (Lawson, 1968 and Vargafting, 1969) 2. BaCl2 model (Papp et al, 1967) 3. Benzene vapours induced arrhythmia (Tripathi and Thomas, 1986) 4. Wenzel and Kloeppel demonstrated that arrhythmias could be induced by changing the medium of cultured heart cells 5. VF production by isoprenaline and COMT inhibitor at high temperature (Sono et al, 1985) 6. Grayanotoxin – I induced arrhythmia in guinea pigs (Takei et al, 1994)
  • 33. Electrically induced arrhythmias 1. Ventricular fibrillation electrical threshold 2. Programmed electrical stimulation induced arrhythmia 3. Sudden coronary death model in dogs (Harris dog model)
  • 34. Ventricular fibrillation electrical threshold Several electrical stimulation techniques are used to measure VF threshold: • Single pulse stimulation • Train of pulses stimulation • Continuous 50 Hz stimulation • Sequential pulse stimulation Animals – adult dogs weighing 8-12 kg Anaesthesia – sodium pentobarbital 35 mg/kg intraperitoneal
  • 35. Ventilation given with Harvard respiratory pump, systolic BP monitored and body temperature maintained with a thermal blanket Chest opened by a midline sternotomy and heart suspended in a pericardial cradle Sinus node crushed and a 2mm diameter Ag-AgCl stimulating electrode embedded in a Teflon disc sutured to ant wall of LV 3-ms square anodal constant current pulses given for 400ms of basic cycle and prematurely restimulated Recording electrode is placed on the surface of each ventricle silver plate is implanted under the skin in the right femoral region as indifferent electrode.
  • 36. Lead II of the body surface ECG is monitored. To determine VF threshold, a 0.2-1.8 second train of 50 Hz pulses is delivered 100ms after every 18th basic driving stimulus. The current intensity is increased from the diastolic threshold in increments of 10μA to 1.0 mA or until VF occurs. Defibrillation given when VF occurs,heart allowed to recover to control conditions for 15-20 minutes. Anti- arrhythmic drugs are given in the femoral vein.
  • 37. Evaluation: VF threshold is determined before and after test drug administration and compared using student’s t-test.
  • 38. Programmed electrical stimulation induced arrhythmias A ligature is tied around the artery and needle. The needle is then removed which causes stenosis of the vessel. LAD is perfused for 5 minutes. Ischemic injury is achieved by 2 hour occlusion of LAD and then again vessel is perfused for 2 hours in presence of stenosis. During reperfusion, an epicardial bipolar electrode is sutured to the IV septum,. Silver disc electrodes are implanted SC for ECG monitoring. Animals with sustained VT and VF are taken for study. HR, ECG are recorded before the PES is started. After 6-9 days, the chest is reopened and PES is performed through electrode implanted on non-infarcted zone with pacing stimuli set at 200ms. After 15 pacing stimulation, an extra stimulus is given
  • 39. • Test drug is given 30 minutes after the stimulus. • The minimum intensity of current needed for sustained VF is recorded before and after test drugs and mean values of 10 experiments are compared by student’s t-test.
  • 40. Sudden coronary death model in dogs • The group of Lucchesi described the experimental dog model for protection against sudden coronary death. Animal - Male Mongrel dogs of 14-22 kg weight Anaesthesia - pentobarbital sodium 30 mg/kg IV.
  • 41. Direct anodal 15μA current from 9-V nickel-cadmium battery passed through a 250 ohm resistor and applied to electrode in the lumen of LCX. Cathode connected to a SC implanted disc electrode and lead II ECG recorded for 30 seconds every 15 minutes on a cardio-cassette recorder. The animals are sacrificed after 24 hours of constant anodal current of at the occurrence of VF. Heart removed and thrombus mass in LCX is removed, weighed. Heart sectioned and stained with tetrazolium triphenyl choride (TTC). Time of onset of ventricular ectopy and lethal arrhythmia recorded using the cassette. Non-sustained and sustained tachyarrhythmia are evaluated
  • 42. Mechanically induced arrhythmias Arrhythmias can be induced by directly by ischemia or and also by re- perfusion. Studies involving both the mechanisms to produce arrhythmias have been demonstrated. 1. Reperfusion arrhythmias in rats 2. VF after coronary occlusion and reperfusion in dogs 3. Two stage ligation in dogs (The Harris dog model)
  • 43. Reperfusion arrhythmias in rats • Ligation of left main coronary artery results in ventricular arrhythmias and MI. • ECG is recorded during ligation and also during reperfusion. • The infarcted tissue is measured by tetrazolium triphenyl chloride staining
  • 44. Sprague Dawley rats (350-400 g) are anaesthetised with pentobarbitone sodium 60 mg/kg IP. The animal is maintained on artificial respiration, jugular vein is cannulated for drug administration. BP is recorded from carotid artery with the help of a pressure transducer connected to a polygraph. Chest is opened and heart is exposed. The left coronary artery is located and ligated for 15-90 minutes (in case of infarct size studies) and subsequently reperfused for 30 minutes.
  • 45. Test drug is given 5 minutes before ligation. The number of ventricular premature beats, VT and VF are counted in the occlusion and reperfusion periods. After the reperfusion period, the animal is sacrificed and TTC staining is done to measure the infarct size.. Changes in hemodynamic parameters and infarct size in drug treated animals are compared with control values.
  • 46. Reperfusion arrhythmias in dogs • Ligation of coronary artery in dogs may lead to increase in HR, LV end diastolic pressure, BP and ventricular arrhythmias especially in reperfusion. • Animal - Dogs of 20-25 kg weight • Anaesthesia: thio-butobarbital sodium 30 mg/kg IP maintained on IV chloralose 20 mg/kg and 250 mg/kg urethane IV followed by SC morphine 2 mg/kg.
  • 47. Changes in parameters (mortality, hemodynamic and arrhythmia) in drug treated animals are compared with controls. Coronary artery is ligated for 90 minutes. Test compound is given 20 minutes prior to ligation and reperfusion is done after the ligation period. LV end diastolic pressure and HR are determined from LV pressure curves. Myocardial contractility is measured as a rise of ventricular pressure. Femoral artery is cannulated to measure BP and connected to a pressure transducer and ECG is recorded continuously in lead II.
  • 48. Two stage ligation in dogs (Harris dog model) • In 1950, Harris found that mortality in dogs after coronary occlusion with a 2 stage ligation procedure was lower than with 1 stage ligation
  • 49. Dogs of 8-11 kg are anaesthetised by IV injection of methohexitone sodium 10 mg/kg and maintained on artificial respiration. Chest is opened and the heart is exposed. Left coronary artery is ligated in 2 stages. Two ligatures are tied around the artery and the 21 gauge needle. 1st ligature is tied around and the needle, which is removed 2nd is tied tightly around the artery (after 30 minutes ). After 24-48 hours of ligation, arrhythmias develop and subside in 3-5 days.
  • 50. • Lead II ECG, atrial electrogram and mean BP are measured. • Test drugs are infused 10 minutes after coronary ligation. • Changes in mortality, hemodynamics and arrhythmias in treated animals are compared with controls.
  • 51. Exercise induced ventricular fibrillation • Billman and his group developed methods to evaluate anti-arrhythmic drugs for their activity in exercise-plus-ischemia induced arrhythmia test.
  • 52. Mongrel dogs 15-19 kg are anaesthetised with sodium pentobarbitone 10 mg/kg IV, chest cavity opened, heart exposed and supported in a pericardial cradle. Around the LCX a 20 MHz pulsed Doppler flow transducer and hydraulic occluder are placed. A pair of insulated silver wires are sutured to the epicardial surface of both the left and right ventricular electrogram. A pre-calibrated solid state pressure transducer is inserted into LV and finally a two stage occlusion of LAD is done.
  • 53. Leads are placed under the skin to exit on the back of the animal’s neck. 3-4 weeks after the production of ischemia, the animal is made to walk on a motor driven treadmill during which susceptibility to VF is tested. 3 minute warm up period - animals run at 6.4 km/hr (0% grade). The grade is increased every 3 minutes from 0%, 4%, 8%, 12% and 16%. In the last minute of exercise, the LCX is occluded, the treadmill stopped and occlusion maintained for an additional minute.
  • 54. • Repeated after the test drug and the findings are compared with the control (saline) group. • All hemodynamic data (rate of change of LV pressure) are recorded. The refractory period data, reactive hyperemia response to each occlusion is averaged and data analysed using ANOVA. • The effect of intervention on arrhythmia formation are determined by chi- square test with Yate’s correction.
  • 55. Cell culture techniques • Ventricular arrhythmias, especially torsades de pointes can be evaluated using isolated ventricular myocytes. • Analysis of action potential and patch clamp techniques in isolated ventricular myocytes helps us to clarify mechanisms underlying development of torsades de pointes.
  • 56. Guinea pigs (250-350 g) are sacrificed by decapitation and their hearts are removed and perfused retrodradely through the aorta at a rate of 10 ml/min with oxygenated calcium free HEPES buffered saline at 37⁰C for 5 minutes. Perfusion with same solution containing 300 U/ml type II collagenase and 0.5- 1.0 U/ml type XIV protease for 8 minutes HEPES buffered saline containing 0.2mM calcium chloride for additional 5 minutes. The cells re-suspended in HEPES buffered saline and stored at 24⁰C.
  • 57. Transmembrane potential is recorded using glass electrodes connected to the Axoclamp 2A amplifier. Cells superfused with HEPES buffered saline at a rate of 2 ml/min at 37⁰C. Passing brief current pulses (1 ms, 1.2 times threshold) through recording electrode with active bridge current evokes action potentials. Cells are stimulated at a frequency of 1 Hz during stabilization period and at a frequencies of 1 and 3 Hz during control and 10 minutes after superfusion with test drugs at cumulatively increasing drug concentration
  • 58. Four individual AP are digitally averaged and measured for each condition. For voltage clamp studies, microelectrodes made from square bore, borosilicate capillary tubing are filled with 0.5 M potassium gluconate, 25 mM KCl, 5 mM K2ATP. Voltage clamp is performed using whole cell recording mode and cell perfusion is minimized by maintaining constant negative pressure on the electrode using 1 ml syringe. Outward K+ currents are measured during superfusion of cells at 2 ml/min with calcium free HEPES buffered saline. Concentration response relations are determined by measuring AP of currents in each cell during control conditions and during superfusion with 2 successively increasing concentrations of a drug.
  • 59. Genetically induced arrhythmias • A certain breed of dogs – German shepherds – exhibit propensity to sudden death that occurs due to inherited ventricular arrhythmias. • Death usually occurs in them during sleep or at rest after exercise or excitement. • These dogs can be used for screening of potential anti-arrhythmic drugs.
  • 60. Conclusion • Species differences do exist in mechanisms producing arrhythmias and no animal can exactly resemble humans • However, knowledge acquired from animal studies can help a great deal in devising therapeutic strategies for both ventricular and supraventricular arrhythmias • Various animal models can be combined to build novel strategies in management of arrhythmias

Editor's Notes

  1. Precautions – handle the animal with care, keep the room calm Storage oscilloscope
  2. Compounds affecting ERP have either pro or anti-arrhythmic effects. Inotropic effects can also be determined.
  3. In 1897.was considered a breakthrough discovery in cardiovascular research.
  4. Heparin to prevent thrombus formation in heart Flow rate: 7-9 ml/min for rat,20 ml/min for rabbit
  5. Rat, guinea pig – Krebs solution Rabbit – McEwen’s solution
  6. 8-10 animals are used per compound Urethane
  7. The minimal current intensity of the pulse train required to induce sustained VF is defined as VFT.
  8. 1. 20 gauge needle. 2. by a silicon rubber snare (produces anterior wall infarction) 3. adjacent to the occlusion site
  9. Sudden coronary death being the leading cause of death, it warrants for use of more complicated models in higher animals for discovery of active drugs.
  10. The heart is dissected and cut into transverse sections (1 mm thick) and stained with TTC prepared in Sorensen phosphate buffer containing 100 mM, L-maleate to visualise the infarct tissue (blue/ violet stained healthy tissue and unstained necrotic tissue). Slices are photographed and infarct area is measured by planimetry from projections of all slices
  11. The experimental procedure is similar to rats.
  12. 3. from which HR is determined by Gould Biotachometer. 4. first partially occluded for 20 minutes and then tied off.
  13. 2. Analgesics and antibiotics are given to minimize the discomfort. Defibrillation is given if animal becomes unconscious and the occlusion is released if VF occurs during experiment.
  14. 4. The heart is digested and cut into small pieces, placed in a 20 ml HEPES buffered saline containing calcium chloride and shaken until single cells are dissociated.
  15. A list EPC-7 clamp amplifier is used to voltage clamp the isolated cells. AP are assessed with three way ANOVA to determine significance within treatment variations. Dunett’s t test s used for significance of individual treatment means compared with control mean values.